Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model

• Published in: Antimicrobial agents and chemotherapy Vol. 64; no. 3
• Main Authors: Tam, Vincent H, Cohen, Daniel N, Ledesma, Kimberly R, Guillory, Bobby, Chan, Katrina, Garey, Kevin W
• Format: Journal Article
• Language: English
• Published: United States American Society for Microbiology 21.02.2020
• Subjects: Animals; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - therapeutic use; Ceftriaxone - administration & dosage; Ceftriaxone - therapeutic use; Experimental Therapeutics; Female; Inflammation - drug therapy; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; injury assessment; inflammation; necrosis
• ISSN: 0066-4804; 1098-6596
• DOI: 10.1128/AAC.02090-19

Subcutaneous administration is a novel way to deliver antibiotics for an infection, but intolerability has been reported. Evaluating the local tolerability of subcutaneously administered antibiotics is not standardized. The goal of this study was to develop an animal model to assess the subcutaneous administration of ceftriaxone. Sprague-Dawley rats were given daily subcutaneous injections for 12 days. The back of each animal was divided into 4 quadrants, with injections rotating each day among the quadrants. Ceftriaxone (1,000 mg/kg of body weight daily) was given in different concentrations and durations. Normal saline and potassium chloride solutions (2 meq/2 ml) were used as negative and positive controls, respectively. After the treatment course, skin samples were biopsied, and the local inflammatory response was assessed histologically using a semiquantitative scoring system. The histopathology scores were compared using a Kruskal-Wallis test. Injections with potassium chloride resulted in full-thickness skin necrosis with subcutaneous atrophy that was not seen in the saline-injected animals; inflammation of the muscular panniculus was observed, with various degrees of myocyte injury. Serosanguinous cavity formation in the subcutaneous compartment was observed when ceftriaxone (125 mg/ml) was given as a bolus injection, but the extent of the local tissue response was remarkably reduced when the same ceftriaxone dose was given at a lower concentration (25 mg/ml) over 120 min (  = 0.63, compared to saline controls). At a low concentration, ceftriaxone infusion was found to be well tolerated in this animal tissue necrosis model. If validated, the model could be an instrumental platform to evaluate different pharmaceutical formulations for subcutaneous delivery.